Friday 6 November 2026 Export BMRN’s income statement to Excel — free account

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 12.9% from fiscal 2024.

Revenue: +32.0%
EPS: −296.6%
Free cash flow: −52.3%
Total debt: +599.5%

Quarter to September 2026, against a year earlier

Revenue growth 3 yrs

55.89 0.23 −0.41%

Follow BMRN

Alert me

Market cap: $10.9B
P/E: 0.0×
Fwd P/E: 32.7×
Dividend yield: —
F-score: 5/9
Altman Z: 5.67
Beneish M: −2.49
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
Piotroski F-Score Full definition →	2	3	4	5	+8 more TTM periods Free account
ROE Full definition →	(0.31%)	1.18%	4.48%	5.94%
ROA Full definition →	(0.20%)	0.76%	3.42%	4.79%
ROIC Full definition →	0.73%	0.97%	3.64%	5.00%
Return on Tangible Assets Full definition →	(0.58%)	2.21%	5.63%	8.41%
Average Days of Receivables Full definition →	107.48	113.69	101.76	102.91
Free Cash Flow per Share Full definition →	2.88	3.75	3.98	3.74
Free Cash Flow Full definition →	557.86	724.81	767.06	717.02
Capital Expenditures Full definition →	(118.75)	(132.28)	(107.19)	(110.97)
Other line items
Cash ROIC Full definition →	5.00%	6.37%	7.78%	8.70%
Accounts Receivable Turnover Full definition →	3.92	3.55	3.95	4.11
Accounts Payable Turnover Full definition →	1.01	0.96	1.07	1.05
Inventory Turnover Full definition →	0.55	0.52	0.60	0.57
Average Days of Payables Full definition →	392.90	451.23	380.48	386.16
Days of Inventory on Hand Full definition →	745.88	799.69	610.77	660.81
Tax Rate Full definition →	(1.44)	(0.51)	(0.30)	(0.28)
Research and Development Expense of Revenue Full definition →	26.80%	28.99%	29.05%	28.62%
Selling, General and Administrative Expense of Revenue Full definition →	39.22%	40.17%	37.17%	35.79%
Share Based Compensation of Revenue Full definition →	6.01%	6.32%	5.77%	5.63%
Interest Coverage Full definition →	0.83	1.79	13.71	37.57
Operating CF/Net income Full definition →	(35.40)	11.75	3.25	2.37
Depreciation/Fixed assets Full definition →	0.27	0.15	0.07	0.08
Capex/Depreciation Full definition →	(0.46)	(0.89)	(1.53)	(1.48)
Revenue per Share Full definition →	18.88	17.61	16.84	16.80
Operating CF per Share Full definition →	3.50	4.43	4.54	4.32
Capex per Share Full definition →	(0.61)	(0.68)	(0.56)	(0.58)
Capex to Sales Full definition →	0.03	0.04	0.03	0.03

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly